Renal Cell Carcinoma
Quiénes somos
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types
Estudio de NGM831 como monoterapia y en combinación con pembrolizumab en tumores sólidos avanzados o metastásicos
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
A Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid Tumors
